Physician

Michael James Reed, M.D.

According to 2025 Medicare claims, Michael Reed, M.D. (NPI: 1417183351) practices otolaryngology in the Iowa City, IA market, with the plurality of this provider's patient population coming from Johnson, IA. This provider's primary affiliated billing organization is ENT MEDICAL SERVICES PC (NPI: 1861448342; TIN: 42-0958173) and primary practice location at 52245-9565.

Reed's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 743 traditional Medicare patients, billed 6,540 HCPCS/CPT codes, and received $262,288 in Medicare payments. The top billing code was 31231 (Diagnostic exam of nasal passages using an endoscope). Part D data shows 1,496 prescription claims across 418 beneficiaries totaling $26,071 in drug costs, led by Epinephrine (Epinephrine). DME data shows 1,191 claims. Open Payments data shows 30 records totaling $696. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has risen steadily, from $141,181 to $262,288. Similarly, Part D prescription costs have moved from a lower plateau to a higher plateau, from $17,547 to $26,071. For DME billing, reported payments moved sharply higher in recent years, from $8,361 to $58,563.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	358	3,817	$141,181
2016	436	3,563	$125,921
2017	484	4,305	$154,129
2018	516	3,945	$162,978
2019	504	4,414	$215,886
2020	510	3,791	$168,058
2021	584	4,858	$238,816
2022	561	4,226	$250,746
2023	719	5,669	$236,761
2024	743	6,540	$262,288

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	194	641	$17,547
2016	216	623	$12,343
2017	240	671	$13,434
2018	239	828	$20,308
2019	252	915	$22,303
2020	264	1,018	$24,171
2021	325	1,167	$27,700
2022	348	1,296	$35,838
2023	380	1,389	$33,326
2024	418	1,496	$26,071

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	44	$2,378
2016	59	126	$3,775
2017	86	253	$5,936
2018	130	329	$12,258
2019	186	420	$16,254
2020	269	540	$25,148
2021	227	541	$25,519
2022	361	712	$36,198
2023	514	1,068	$55,439
2024	581	1,191	$57,050

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
31231	Diagnostic exam of nasal passages using an endoscope	259	383	$113
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	440	634	$78
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	352	478	$56
92557	Comprehensive hearing and speech recognition test	211	242	$22
92567	Test to assess middle ear function	211	242	$10

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Epinephrine	Epinephrine	28	488	$5,035
Ipratropium Bromide	Ipratropium Bromide	91	2,677	$3,602
Pantoprazole Sodium	Pantoprazole Sodium	237	11,301	$2,060
Cefdinir	Cefdinir	44	460	$1,027
Ofloxacin	Ofloxacin	37	464	$919

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
E0601	Continuous positive airway pressure (cpap) device	Y	34	198	$8,021
A7031	Face mask interface, replacement for full face mask, each	N	30	70	$7,216
A7030	Full face mask used with positive airway pressure device, each	N	34	67	$6,993
A7034	Nasal interface (mask or cannula type) used with positive airway pressure device, with or without head strap	N	61	111	$6,376
A4604	Tubing with integrated heating element for use with positive airway pressure device	N	74	157	$6,112

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	30	$696	Integra LifeSciences Corporation
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Michael James Reed, M.D.?

Tedicare shows public-source Medicare data for Michael James Reed, M.D. (NPI 1417183351), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Michael James Reed, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Michael James Reed, M.D.?

Michael James Reed, M.D. is linked to ENT MEDICAL SERVICES PC (billing NPI 1861448342) in the available physician profile data.

Does Michael James Reed, M.D. have Open Payments data?

Michael James Reed, M.D. has 30 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.